ParkinsonCanadaV1, PubMed, Corpus, bibRecord, 000F53

Severe left ventricular dysfunction in infants with ventricular preexcitation.

Identifieur interne : 000F53 ( PubMed/Corpus ); précédent : 000F52; suivant : 000F54

Severe left ventricular dysfunction in infants with ventricular preexcitation.

Auteurs : Julia Cadrin-Tourigny ; Anne Fournier ; Gregor Andelfinger ; Paul Khairy

Source :

Heart rhythm [ 1556-3871 ] ; 2008.

RBID : pubmed:18774110

English descriptors

KwdEn :
- Adrenergic alpha-Antagonists (therapeutic use), Amiodarone (therapeutic use), Anti-Arrhythmia Agents (therapeutic use), Carbazoles (therapeutic use), Cardiomyopathy, Dilated (drug therapy), Cardiomyopathy, Dilated (physiopathology), Cardiotonic Agents (therapeutic use), Diuretics (therapeutic use), Female, Furosemide (therapeutic use), Humans, Infant, Propanolamines (therapeutic use), Risk Factors, Ventricular Dysfunction, Left (drug therapy), Ventricular Dysfunction, Left (physiopathology), Ventricular Premature Complexes (drug therapy), Ventricular Premature Complexes (physiopathology), Wolff-Parkinson-White Syndrome (drug therapy), Wolff-Parkinson-White Syndrome (physiopathology).
MESH :
- chemical , therapeutic use : Adrenergic alpha-Antagonists, Amiodarone, Anti-Arrhythmia Agents, Carbazoles, Cardiotonic Agents, Diuretics, Furosemide, Propanolamines.
- drug therapy : Cardiomyopathy, Dilated, Ventricular Dysfunction, Left, Ventricular Premature Complexes, Wolff-Parkinson-White Syndrome.
- physiopathology : Cardiomyopathy, Dilated, Ventricular Dysfunction, Left, Ventricular Premature Complexes, Wolff-Parkinson-White Syndrome.
- Female, Humans, Infant, Risk Factors.

DOI: 10.1016/j.hrthm.2008.05.022
PubMed: 18774110

Links to Exploration step

pubmed:18774110

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Severe left ventricular dysfunction in infants with ventricular preexcitation.</title>
<author><name sortKey="Cadrin Tourigny, Julia" sort="Cadrin Tourigny, Julia" uniqKey="Cadrin Tourigny J" first="Julia" last="Cadrin-Tourigny">Julia Cadrin-Tourigny</name>
<affiliation><nlm:affiliation>Electrophysiology Service, Montreal Heart Institute, University of Montreal, Montreal, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Fournier, Anne" sort="Fournier, Anne" uniqKey="Fournier A" first="Anne" last="Fournier">Anne Fournier</name>
</author>
<author><name sortKey="Andelfinger, Gregor" sort="Andelfinger, Gregor" uniqKey="Andelfinger G" first="Gregor" last="Andelfinger">Gregor Andelfinger</name>
</author>
<author><name sortKey="Khairy, Paul" sort="Khairy, Paul" uniqKey="Khairy P" first="Paul" last="Khairy">Paul Khairy</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:18774110</idno>
<idno type="pmid">18774110</idno>
<idno type="doi">10.1016/j.hrthm.2008.05.022</idno>
<idno type="wicri:Area/PubMed/Corpus">000F53</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F53</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Severe left ventricular dysfunction in infants with ventricular preexcitation.</title>
<author><name sortKey="Cadrin Tourigny, Julia" sort="Cadrin Tourigny, Julia" uniqKey="Cadrin Tourigny J" first="Julia" last="Cadrin-Tourigny">Julia Cadrin-Tourigny</name>
<affiliation><nlm:affiliation>Electrophysiology Service, Montreal Heart Institute, University of Montreal, Montreal, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Fournier, Anne" sort="Fournier, Anne" uniqKey="Fournier A" first="Anne" last="Fournier">Anne Fournier</name>
</author>
<author><name sortKey="Andelfinger, Gregor" sort="Andelfinger, Gregor" uniqKey="Andelfinger G" first="Gregor" last="Andelfinger">Gregor Andelfinger</name>
</author>
<author><name sortKey="Khairy, Paul" sort="Khairy, Paul" uniqKey="Khairy P" first="Paul" last="Khairy">Paul Khairy</name>
</author>
</analytic>
<series><title level="j">Heart rhythm</title>
<idno type="eISSN">1556-3871</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenergic alpha-Antagonists (therapeutic use)</term>
<term>Amiodarone (therapeutic use)</term>
<term>Anti-Arrhythmia Agents (therapeutic use)</term>
<term>Carbazoles (therapeutic use)</term>
<term>Cardiomyopathy, Dilated (drug therapy)</term>
<term>Cardiomyopathy, Dilated (physiopathology)</term>
<term>Cardiotonic Agents (therapeutic use)</term>
<term>Diuretics (therapeutic use)</term>
<term>Female</term>
<term>Furosemide (therapeutic use)</term>
<term>Humans</term>
<term>Infant</term>
<term>Propanolamines (therapeutic use)</term>
<term>Risk Factors</term>
<term>Ventricular Dysfunction, Left (drug therapy)</term>
<term>Ventricular Dysfunction, Left (physiopathology)</term>
<term>Ventricular Premature Complexes (drug therapy)</term>
<term>Ventricular Premature Complexes (physiopathology)</term>
<term>Wolff-Parkinson-White Syndrome (drug therapy)</term>
<term>Wolff-Parkinson-White Syndrome (physiopathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenergic alpha-Antagonists</term>
<term>Amiodarone</term>
<term>Anti-Arrhythmia Agents</term>
<term>Carbazoles</term>
<term>Cardiotonic Agents</term>
<term>Diuretics</term>
<term>Furosemide</term>
<term>Propanolamines</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Cardiomyopathy, Dilated</term>
<term>Ventricular Dysfunction, Left</term>
<term>Ventricular Premature Complexes</term>
<term>Wolff-Parkinson-White Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Cardiomyopathy, Dilated</term>
<term>Ventricular Dysfunction, Left</term>
<term>Ventricular Premature Complexes</term>
<term>Wolff-Parkinson-White Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Risk Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18774110</PMID>
<DateCreated><Year>2008</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted><Year>2009</Year>
<Month>02</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>12</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>5</Volume>
<Issue>9</Issue>
<PubDate><Year>2008</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Heart rhythm</Title>
<ISOAbbreviation>Heart Rhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>Severe left ventricular dysfunction in infants with ventricular preexcitation.</ArticleTitle>
<Pagination><MedlinePgn>1320-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2008.05.022</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cadrin-Tourigny</LastName>
<ForeName>Julia</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Electrophysiology Service, Montreal Heart Institute, University of Montreal, Montreal, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fournier</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Andelfinger</LastName>
<ForeName>Gregor</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Khairy</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2008</Year>
<Month>08</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Heart Rhythm</MedlineTA>
<NlmUniqueID>101200317</NlmUniqueID>
<ISSNLinking>1547-5271</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000317">Adrenergic alpha-Antagonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002227">Carbazoles</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002316">Cardiotonic Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004232">Diuretics</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011412">Propanolamines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0K47UL67F2</RegistryNumber>
<NameOfSubstance UI="C043211">carvedilol</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>7LXU5N7ZO5</RegistryNumber>
<NameOfSubstance UI="D005665">Furosemide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>N3RQ532IUT</RegistryNumber>
<NameOfSubstance UI="D000638">Amiodarone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000317" MajorTopicYN="N">Adrenergic alpha-Antagonists</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000638" MajorTopicYN="N">Amiodarone</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002227" MajorTopicYN="N">Carbazoles</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002311" MajorTopicYN="N">Cardiomyopathy, Dilated</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002316" MajorTopicYN="N">Cardiotonic Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004232" MajorTopicYN="N">Diuretics</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005665" MajorTopicYN="N">Furosemide</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011412" MajorTopicYN="N">Propanolamines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018487" MajorTopicYN="N">Ventricular Dysfunction, Left</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018879" MajorTopicYN="N">Ventricular Premature Complexes</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014927" MajorTopicYN="N">Wolff-Parkinson-White Syndrome</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year>
<Month>04</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2008</Year>
<Month>05</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2008</Year>
<Month>9</Month>
<Day>9</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>2</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2008</Year>
<Month>9</Month>
<Day>9</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">18774110</ArticleId>
<ArticleId IdType="pii">S1547-5271(08)00567-5</ArticleId>
<ArticleId IdType="doi">10.1016/j.hrthm.2008.05.022</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F53 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000F53 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:18774110
   |texte=   Severe left ventricular dysfunction in infants with ventricular preexcitation.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:18774110" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Severe left ventricular dysfunction in infants with ventricular preexcitation.

Severe left ventricular dysfunction in infants with ventricular preexcitation.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki